Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Quinn, Joseph
2003.
Vascular Dementia.
Journal of the American Medical Directors Association,
Vol. 4,
Issue. 6,
p.
S155.
Jönsson, Linus
2003.
Pharmacoeconomics of cholinesterase inhibitors in the treatment of Alzheimer’s disease.
PharmacoEconomics,
Vol. 21,
Issue. 14,
p.
1025.
Birks, JS
Harvey, R
and
Birks, Jacqueline
2003.
Cochrane Database of Systematic Reviews.
Doggrell, Sheila A
and
Evans, Suzanne
2003.
Treatment of dementia with neurotransmission modulation.
Expert Opinion on Investigational Drugs,
Vol. 12,
Issue. 10,
p.
1633.
Feldman, Howard
Gauthier, Serge
Hecker, Jane
Vellas, Bruno
Emir, Birol
Mastey, Vera
Subbiah, Ponni
and
The Donepezil MSAD Study Investigators Group
2003.
Efficacy of Donepezil on Maintenance of Activities of Daily Living in Patients with Moderate to Severe Alzheimer's Disease and the Effect on Caregiver Burden.
Journal of the American Geriatrics Society,
Vol. 51,
Issue. 6,
p.
737.
Quinn, Joseph
2003.
Vascular Dementia.
Journal of the American Medical Directors Association,
Vol. 4,
Issue. 6,
p.
S155.
2003.
Current awareness in geriatric psychiatry.
International Journal of Geriatric Psychiatry,
Vol. 18,
Issue. 8,
p.
761.
Feldman, H.
Gauthier, S.
Hecker, J.
Vellas, B.
Hux, M.
Xu, Y.
Schwam, E.M.
Shah, S.
and
Mastey, V.
2004.
Economic evaluation of donepezil in moderate to severe Alzheimer disease.
Neurology,
Vol. 63,
Issue. 4,
p.
644.
Dolder, Christian R.
2004.
Diagnosis and treatment of psychiatric and behavioral disturbances in alzheimer disease: A review of recent literature.
Current Psychosis and Therapeutics Reports,
Vol. 2,
Issue. 1,
p.
13.
Boyle, Patricia A.
and
Malloy, Paul F.
2004.
Treating Apathy in Alzheimer’s Disease.
Dementia and Geriatric Cognitive Disorders,
Vol. 17,
Issue. 1-2,
p.
91.
Wilkinson, David G
Francis, Paul T
Schwam, Elias
and
Payne-Parrish, Jennifer
2004.
Cholinesterase Inhibitors Used in the Treatment of Alzheimer???s Disease.
Drugs & Aging,
Vol. 21,
Issue. 7,
p.
453.
Marksteiner, Josef
and
Schmidt, Reinhold
2004.
Treatment Strategies in Alzheimer???s Disease with a Focus on Early Pharmacological Interventions.
Drugs & Aging,
Vol. 21,
Issue. 7,
p.
415.
Wynn, Zakiya J.
and
Cummings, Jeffrey L.
2004.
Cholinesterase Inhibitor Therapies and Neuropsychiatric Manifestations of Alzheimer’s Disease.
Dementia and Geriatric Cognitive Disorders,
Vol. 17,
Issue. 1-2,
p.
100.
Román, Gustavo C
and
Rogers, Susan J
2004.
Donepezil: a clinical review of current and emerging indications.
Expert Opinion on Pharmacotherapy,
Vol. 5,
Issue. 1,
p.
161.
Cummings, Jeffrey L.
2005.
Behavioral and Neuropsychiatric Outcomes in Alzheimer's Disease.
CNS Spectrums,
Vol. 10,
Issue. S18,
p.
22.
Fillit, Howard
and
Hill, Jerrold
2005.
Economics of dementia and pharmacoeconomics of dementia therapy.
The American Journal of Geriatric Pharmacotherapy,
Vol. 3,
Issue. 1,
p.
39.
Gauthier, S.
Wirth, Y.
and
Möbius, H. J.
2005.
Effects of memantine on behavioural symptoms in Alzheimer's disease patients: an analysis of the Neuropsychiatric Inventory (NPI) data of two randomised, controlled studies.
International Journal of Geriatric Psychiatry,
Vol. 20,
Issue. 5,
p.
459.
Herrmann, Nathan
Rabheru, Kiran
Wang, Jenny
and
Binder, Carin
2005.
Galantamine Treatment of Problematic Behavior in Alzheimer Disease: Post-Hoc Analysis of Pooled Data From Three Large Trials.
The American Journal of Geriatric Psychiatry,
Vol. 13,
Issue. 6,
p.
527.
Harrison, Barbara E.
Therrien, Barbara A.
and
Giordani, Bruno J.
2005.
Alzheimer's disease behaviors from past self-identities: An exploration of the memory and cognitive features.
American Journal of Alzheimer's Disease & Other Dementias®,
Vol. 20,
Issue. 4,
p.
248.
Cummings, Jeffrey L.
2005.
Neuropsychiatric and behavioral alterations and their management in moderate to severe Alzheimer disease.
Neurology,
Vol. 65,
Issue. 6_suppl_3,